Development of an Algorithm to Differentiate Uterine Sarcoma from Fibroids Using MRI and LDH Levels
Diagnostics, 2023 Background: This study aimed to establish an evaluation method for detecting uterine sarcoma with 100% sensitivity using MRI and serum LDH levels. Methods: One evaluator reviewed the MRI images and LDH values of a total of 1801 cases, including 36 cases ...
Aki Kido, Ayako Suzuki, Tomoyuki Otani
exaly +4 more sources
Intraperitoneal spread in uterine sarcoma following unprotected laparoscopic transvaginal uterine morcellation: a case report and literature review [PDF]
Frontiers in OncologyClinically and through auxiliary examinations, distinguishing uterine leiomyoma from early-stage uterine sarcoma presents significant challenges. A 48-year-old patient underwent a laparoscopic hysterectomy for uterine leiomyoma, during which a large ...
Jianhao Sun +11 more
doaj +4 more sources
KAT6B/A::KANSL1 uterine sarcoma – A case with recurrences following uterine morcellation and the development of primary cell line model [PDF]
Gynecologic Oncology ReportsBackground: KAT6B/A::KANSL1 uterine sarcoma has been recently recognized as a distinct type of uterine sarcoma displaying mixed endometrial stromal and smooth muscle features.
Lauren Chen +8 more
doaj +2 more sources
Uterine sarcoma Part II—Uterine endometrial stromal sarcoma: The TAG systematic review [PDF]
Taiwanese Journal of Obstetrics & Gynecology, 2016 Endometrial stromal tumors are rare uterine tumors (
Huann-Cheng Horng +88 more
doaj +2 more sources
Prolapsed uterine sarcoma causing non-puerperal uterine inversion in a post menopausal woman
Journal of Nepal Medical Association, 2006 A rare case of non-puerperal uterine inversion caused by a large fundal sarcoma in a 57 year old menopausal woman who presented with profuse vaginal bleeding is reported.
Upendra Pandit
doaj +2 more sources
Development of a blood test for uterine sarcoma-Diagnosis and monitoring (DOORS-D and DOORS-M) studies. [PDF]
PLoS ONEUterine sarcomas can be difficult to differentiate from uterine fibroids due to many shared symptoms and imaging features, which can result in delayed or missed diagnosis, or over treatment.
Anna Casey +9 more
doaj +2 more sources
Uterine sarcoma Part I—Uterine leiomyosarcoma: The Topic Advisory Group systematic review [PDF]
Taiwanese Journal of Obstetrics & Gynecology, 2016 Uterine sarcomas account for 3–7% of all uterine cancers. Because of their rarity, unknown etiology, and highly divergent genetic aberration, there is a lack of consensus on risk factors for occurrence and predictive poor outcomes as well as optimal ...
Kuo-Chang Wen +88 more
doaj +2 more sources
Diagnostic and prognostic values of circulating growth differentiation factor-15 and osteopontin in uterine sarcoma [PDF]
Scientific ReportsUterine sarcoma is an aggressive malignancy that is difficult to distinguish from benign leiomyomas pre-operatively. This study aimed to identify circulating biomarkers to improve differential diagnosis and prognostication. The serum and tissue levels of
Hideaki Tsuyoshi +5 more
doaj +2 more sources
International Journal of HyperthermiaObjective To develop a diagnostic model for predicting occult uterine sarcoma in patients with presumed uterine fibroids.Materials and methods We retrospectively reviewed 41631 patients with presumed uterine fibroids who presented for HIFU treatment in ...
Qian Wang +6 more
doaj +2 more sources
Case Report: A case of COL1A1–PDGFB fusion uterine sarcoma at cervix and insights into the clinical management of rare uterine sarcoma [PDF]
Frontiers in Oncology, 2023 COL1A1–PDGFB gene fusion uterine sarcoma is an especially rare malignant mesenchymal tumor that was previously classified as an undifferentiated uterine sarcoma due to the lack of specific features of differentiation.
Linghui Lu +6 more
doaj +2 more sources